← Insider buys
RCUS

Arcus Biosciences, Inc. · Healthcare

COO Jennifer Jarrett sold $45K of Arcus Biosciences, Inc.

Sold$44,700
$23.53Price
1,900Shares

What RCUS did after the filing

Filed Jan 30Copier in Jan 31
The stock from Tue, Jan 31 open, $22.09
−23.2%
S&P 500, same days
−3.0%

Measured over 30 trading days, to the Mar 15 close.

Traded Thu, Jan 26. Filed Mon, Jan 30, 5:04 PM ET, after the close. Returns use the Jan 31 open and the Mar 15 close. Not investment advice.